Clinical Trial Update: Intracardiac CD133+ Cells in Patients With No-option Resistant Angina [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on intracardiac CD133+ cell therapy for patients with no-option resistant angina, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Angina

Drugs mentioned

• intracardiac CD133+ cells (CD133+ cells)

Snippet

Sponsor: Medical University of Silesia | Conditions: Stable Angina | Phase 2 | Status: COMPLETED